FOLFIRINOX as induction treatment in rectal cancer patients with synchronous metastases: Results of the FFCD 1102 phase II trial
- 1 November 2018
- journal article
- research article
- Published by Elsevier in European Journal of Cancer
- Vol. 104, 108-116
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Response of liver metastases to preoperative radiochemotherapy in patients with locally advanced rectal cancer and resectable synchronous liver metastasesSurgery, 2013
- Anastomotic Leak Following Low Anterior Resection in Stage IV Rectal Cancer is Associated with Poor SurvivalAnnals of Surgical Oncology, 2013
- Control of pelvic symptoms in patients with rectal cancer and synchronous metastasesGastroentérologie Clinique Et Biologique, 2009
- Management of patients with asymptomatic colorectal cancer and synchronous irresectable metastasesAnnals of Oncology, 2008
- Phase III Trial of Infusional Fluorouracil, Leucovorin, Oxaliplatin, and Irinotecan (FOLFOXIRI) Compared With Infusional Fluorouracil, Leucovorin, and Irinotecan (FOLFIRI) As First-Line Treatment for Metastatic Colorectal Cancer: The Gruppo Oncologico Nord OvestJournal of Clinical Oncology, 2007
- Treatment strategy for patients with colorectal cancer and synchronous irresectable liver metastasesBritish Journal of Surgery, 2005
- First-line treatment of metastatic colorectal cancer with irinotecan, oxaliplatin and 5-fluorouracil/leucovorin (FOLFOXIRI): results of a phase II study with a simplified biweekly scheduleAnnals of Oncology, 2004
- FOLFIRI Followed by FOLFOX6 or the Reverse Sequence in Advanced Colorectal Cancer: A Randomized GERCOR StudyJournal of Clinical Oncology, 2004
- Radical resection of rectal cancer primary tumor provides effective local therapy in patients with stage IV diseaseAnnals of Surgical Oncology, 2002
- Preoperative Radiotherapy Combined with Total Mesorectal Excision for Resectable Rectal CancerNew England Journal of Medicine, 2001